KansenBio
Latest round
- Angel
Last raised
- Mar 2024
Total raised
- Undisclosed
Investors
- 4
About KansenBio
, trading as KansenBio, is a biotechnology company that provides high-value-added products and low-carbon chemicals, with over a decade of experience in the field of synthetic biology, which is established by Tsinghua University for the conversion of scientific and technological achievements. The Chief Scientist Officer, Zhen Chen is an associate professor at the Department of Chemical Engineering, Tsinghua University. The company is committed to the research, development, and manufacturing of high-value-added products and low-carbon chemicals based on synthetic biotechnology and fermentation-separation-amplification system integration technology. The products include biobased nutrition and active molecules, biobased materials and polymer monomers, and amino acids, which can be applied in cosmetics and personal care, lithium-ion battery materials, and other fields. The company's revenue is generated by providing bio-based monomers and materials, amino acids and their derivatives.
Who invested in KansenBio
4 investors across 1 round
See all investors in KansenBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Mar 29, 2024
Amount
Undisclosed
Investors
Questions about KansenBio
Who invested in KansenBio?
KansenBio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KansenBio raised?
KansenBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KansenBio last raise money?
KansenBio's most recent round on record is a Angel, in Mar 2024.
What does KansenBio do?
, trading as KansenBio, is a biotechnology company that provides high-value-added products and low-carbon chemicals, with over a decade of experience in the field of synthetic biology, which is established by Tsinghua University for the conversion of scientific and technological achievements.
Where is KansenBio headquartered?
KansenBio is headquartered in Beijing, China.
Which VCs invest in companies like KansenBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at KansenBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like KansenBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.